NYSEAMERICAN:VTAK

Catheter Precision Q1 2026 Earnings Results & Report

Catheter Precision logo
$0.15 0.00 (0.00%)
As of 10/9/2026

Catheter Precision beat analyst earnings expectations but missed on revenue in its Q1 2026 results, released May 18, 2026. The company reported EPS of -$13.90 versus the -$209.00 consensus estimate, while revenue of $432 thousand fell short of the $1.60 million estimate by $1.17 million.

Earnings Announcement Details

Quarter
Q1 2026
Report Date
Time
After Market Closes

Catheter Precision EPS Results

Actual EPS
-$13.90
Consensus EPS
-$209.00
Beat/Miss
Beat by +$195.10
One Year Ago EPS
N/A

Catheter Precision Revenue Results

Actual Revenue
$432 thousand
Expected Revenue
$1.60 million
Beat/Miss
Missed by -$1.17 million
YoY Revenue Growth
N/A

Conference Call Resources

Catheter Precision Q1 2026 Earnings FAQ

Catheter Precision (NYSEAMERICAN:VTAK) reported earnings of -$13.90 per share for Q1 2026, beating the consensus estimate of -$209.00. The report was announced on Monday, May 18, 2026.

Catheter Precision reported revenue of $432 thousand for Q1 2026, against a consensus estimate of $1.60 million.

Catheter Precision Earnings Headlines

What the hell is going on?
Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.tc pixel
See More Catheter Precision Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Catheter Precision? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Catheter Precision and other key companies, straight to your email.

About Catheter Precision

Catheter Precision (NYSEAMERICAN:VTAK) is a medical technology company focused on products for electrophysiology, the specialty concerned with diagnosing and treating abnormal heart rhythms. Its products are designed to support clinicians during procedures involving cardiac arrhythmias.

The company’s VIVO system uses patient-specific imaging and electrical data to create a three-dimensional view of the heart and help clinicians locate the source of ventricular arrhythmias before ablation procedures. Catheter Precision also offers LockeT, a device intended to assist with closure of femoral venous access sites after procedures.

Catheter Precision’s product portfolio reflects its focus on tools for planning and supporting electrophysiology procedures. Its shares trade on the NYSE American under the symbol VTAK.

View Catheter Precision Profile